1. 422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts. (9th November 2020) Authors: Middleton, Mark; Aroldi, Francesca; Sacco, Joseph; Milhem, Mohammed; Curti, Brendan; MBioeth, Ari VanderWalde; Baum, Scott; Samson, Adel; Pavlick, Anna; Chesney, Jason; Niu, Jiaxin; Rhodes, Terence; Bowles, Tawnya; Conry, Robert; Olsson-Brown, Anna; Laux, Douglas Earl; Kaufman, Howard; Bommareddy... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a melanoma. (9th November 2020) Authors: Dummer, Reinhard; Gyorki, David; Hyngstrom, John; Berger, Adam; Conry, Robert; Demidov, Lev; Chan, Edward; Radcliffe, Hoi-Shen; Faries, Mark; Ross, Merrick Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a melanoma. (9th November 2020) Authors: Dummer, Reinhard; Gyorki, David; Hyngstrom, John; Berger, Adam; Conry, Robert; Demidov, Lev; Chan, Edward; Radcliffe, Hoi-Shen; Faries, Mark; Ross, Merrick Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients. Issue 1 (December 2016) Authors: Conry, Robert; Rodriguez, Michael; Pressey, Joseph Journal: Clinical sarcoma research Issue: Volume 6:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2018) Authors: Dreno, Brigitte; Thompson, John F; Smithers, Bernard Mark; Santinami, Mario; Jouary, Thomas; Gutzmer, Ralf; Levchenko, Evgeny; Rutkowski, Piotr; Grob, Jean-Jacques; Korovin, Sergii; Drucis, Kamil; Grange, Florent; Machet, Laurent; Hersey, Peter; Krajsova, Ivana; Testori, Alessandro; Conry, Robert... Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗